The Foundation
Advancing coronary intervention without permanent metallic implants
A global collaborative platform for the science, evidence and practice of drug-coated balloon PCI — built on education, research and cross-society partnership.
Stentless PCI was established following the successful inaugural Asia-Pacific StentlessPCI Meeting, held in Chennai, India, in April 2026. What began as the first dedicated regional meeting focused on drug-coated balloon (DCB)-based coronary intervention has since evolved into an international organisation committed to advancing the science and practice of stentless PCI.
Through education, research and scientific collaboration, we seek to advance safe, evidence-based stentless PCI strategies and improve long-term patient outcomes.
We look forward to working closely with national, regional and international cardiovascular societies, academic institutions and healthcare organisations to foster collaboration, promote innovation and support the continued evolution of stentless PCI.
Education, Research & Collaboration
Stentless PCI serves as a global collaborative platform advancing coronary intervention without permanent metallic implants, with a particular focus on vascular repair and restoration.
- Education — courses, live case transmission, hands-on training
- Research — evidence generation for DCB-first strategies
- Collaboration — with cardiovascular societies worldwide
What Drives Us
Vision & Mission
Vision
A future where coronary intervention prioritises vascular restoration and minimises the need for permanent metallic implants.
Mission
To advance the science and practice of stentless PCI through education, research and international collaboration, promoting safe, evidence-based strategies that improve long-term patient outcomes.
Leadership
Scientific Board
Working Together
Collaborating Organisations


